
The integration of biological elements into psychiatric diagnostics could accelerate the development of more objective, data-driven treatments and drug discovery, potentially impacting pharmaceutical R&D and healthcare technology sectors. This shift may also influence regulatory frameworks for mental health interventions.
An AI breakdown of exactly what changed and who it moves.